Cue Biopharma, Inc. (CUE) › Net IncomeCue Biopharma, Inc. (CUE) — Net IncomeAnnual figures by fiscal year, from SEC filings.2017: -$23.23M2018: -$38.98M2019: -$36.70M2020: -$44.78M2021: -$44.16M2022: -$53.01M2023: -$50.73M2024: -$40.67M2025: -$26.60M-$26.60M2017Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$26.60M+34.6%2024-$40.67M+19.8%2023-$50.73M+4.3%2022-$53.01M-20.0%2021-$44.16M+1.4%2020-$44.78M-22.0%2019-$36.70M+5.9%2018-$38.98M-67.8%2017-$23.23M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share